Last reviewed · How we verify

NCT03515330

A Pilot Study of mDOT for Immunosuppressant Adherence in Adult Liver Transplant Recipients

Withdrawn NA Last updated 23 September 2021
What this trial tests

NA trial testing mHealth Intervention in Medication Adherence. Withdrawn.

Timeline
29 June 2020
Primary endpoint
12 November 2020
12 November 2020

Quick facts

Lead sponsorJohns Hopkins University
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Start date29 June 2020
Primary completion12 November 2020
Estimated completion12 November 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Johns Hopkins University

Who can join

22 and older, any sex, with Medication Adherence or Liver Transplant. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators are interested in whether or not the use of a mobile health (mHealth) application increases the rate of immunosuppressant medication adherence among adult liver transplant recipients. The investigators aim to test this by randomly assigning transplant recipients to the intervention (use of an mHealth app to manage and track their immunosuppression regimen) or control arm (standard of care) upon discharge from their initial transplant hospitalization, and tracking medication adherence over time. The study population will be approximately 50 adult liver transplant recipients at the Johns Hopkins Hospital.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Interventions for increasing immunosuppressant medication adherence in solid organ transplant recipients.
    Mellon L, Doyle F, Hickey A, Ward KD, et al · · 2022 · cited 20× · PMID 36094829 · DOI 10.1002/14651858.cd012854.pub2

Verify or expand the search:

Other trials of mHealth Intervention

Trials testing the same drug.

Other recruiting trials for Medication Adherence

Currently open trials in the same condition.

Other Johns Hopkins University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03515330.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing